Join
Live feed
·
INSIDERFilingvia Quantisnow
Candel Therapeutics Inc. logo

Chief Technology Officer Tyagarajan Seshu sold $275,947 worth of shares (31,278 units at $8.82), decreasing direct ownership by 27% to 85,512 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CADL· Candel Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CADL (Candel Therapeutics Inc.) and more on Quantisnow.

Chief Technology Officer Tyagarajan Seshu sold $275,947 worth of shares (31,278 units at $8.82), decreasing direct ownership by 27% to 85,512 units (SEC Form 4) | Quantisnow